Identification and characterisation of human pathogenic filamentous fungi and susceptibility to Thymus schimperi essential oil

Mycoses
Rita PagiottiRoberto Venanzoni

Abstract

Twenty-eight clinical fungal isolates were characterised by morphological (macro- and micro-features and growth response at 25, 30 and 37°C) and molecular (nuclear rDNA-internal transcriber spacer, calmodulin, cytochrome c oxidase 1 and the largest subunit of RNA polymerase II) analyses. The clinical fungal isolates were ascribed to the following taxa: Penicillium chrysogenum, Verticillium sp., Aspergillus tubingensis, Aspergillus minutus, Beauveria bassiana and Microsporum gypseum. In addition, in vitro susceptibility testing of the isolates to conventional antifungal agents and to two chemically well-defined chemotypes of Thymus schimperi essential oil was performed. Most of the isolates were resistant to amphotericin B (except A. minutus), and itraconazole, while terbinafine was quite active on these fungi. T. schimperi essential oil showed antifungal activity against all of the tested fungal isolates with minimal inhibitory concentration values similar or lower than those of terbinafine. Transmission electron microscopy analyses revealed that fungal growth inhibition by essential oil was accompanied by marked morphological and cytological changes.

References

Jul 10, 1999·Clinical Microbiology Reviews·J GuarroA M Stchigel
Jul 29, 1999·Mycoses·R López-MartínezA González-Mendoza
Nov 6, 2004·Journal of Clinical Microbiology·D L TuckerK Rogers
Sep 24, 2005·Mycological Research·Malena P PantouMilton A Typas
Oct 19, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Scott K Fridkin
Dec 24, 2005·Parasitology Research·Everton Kort Kamp FernandesVânia Rita Elias Pinheiro Bittencourt
Mar 1, 2006·Indian Journal of Medical Microbiology·G BashirT Fazili
Jul 25, 2006·Bio Systems·Long Wang, Wen-Ying Zhuang
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Keith A SeifertPaul D N Hebert
May 10, 2007·Molecular Biology and Evolution·Koichiro TamuraSudhir Kumar
May 21, 2008·Studies in Mycology·R A SamsonJ Varga
May 21, 2008·Studies in Mycology·D M GeiserR A Samson
May 21, 2008·Studies in Mycology·J HoubrakenR A Samson
May 21, 2008·Studies in Mycology·S A BalajeeR A Samson
Aug 22, 2008·Diagnostic Microbiology and Infectious Disease·Chi-Jung WuWen-Chien Ko
Jan 17, 2009·Journal of Ethnopharmacology·J DemmaB Hellman
Aug 18, 2009·Revista Da Sociedade Brasileira De Medicina Tropical·Crystiane Rodrigues Araújo MotaMaria do Rosário Rodrigues Silva
Jan 1, 2008·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Danielle Patrícia Cerqueira MacêdoFlávia Cadengue Lopes

❮ Previous
Next ❯

Citations

May 25, 2013·Journal of the American Society for Mass Spectrometry·Daniel KavanVladimir Havlicek
Jan 16, 2020·Biomolecules·Tomasz M Karpiński
May 31, 2021·Mycopathologia·Mohammad Javad NajafzadehJos Houbraken

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.